TABLE 2.
The absolute change in healthcare utilization and spending
| Stomach cancer | Colorectal cancer | Lung cancer | Liver cancer | Breast cancer | Prostate cancer | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre‐policy | Post‐policy | Pre‐policy | Post‐policy | Pre‐policy | Post‐policy | Pre‐policy | Post‐policy | Pre‐policy | Post‐policy | Pre‐policy | Post‐policy | |
| Utilization | ||||||||||||
| Length of stay in hospital per patient (days) | 40.1 ± 70.5 | 39.6 ± 77.2 | 52.5 ± 85.0 | 54.1 ± 93.9 | 58.0 ± 77.5 | 57.5 ± 81.8 | 47.5 ± 63.5 | 48.2 ± 70.0 | 45.7 ± 80.7 | 53.8 ± 101.8 | 31.0 ± 77.3 | 33.9 ± 91.2 |
| Outpatient visits per patient (days) | 21.1 ± 19.4 | 20.8 ± 18.6 | 29.7 ± 28.4 | 28.6 ± 28.2 | 29.0 ± 29.9 | 28.6 ± 29.9 | 24.3 ± 21.9 | 24.5 ±24.6 | 57.9 ± 38.0 | 60.2 ±38.8 | 28.0 ± 24.0 | 27.0 ± 23.6 |
| Expenditure | ||||||||||||
| Medical expenditure per patient (thousand USD) | 9.2 | 9.6 | 13.7 | 13.8 | 15.2 | 14.9 | 13.8 | 14.8 | 16.6 | 17.6 | 7.6 | 8.2 |
| Medical costs in inpatient per patient (thousand USD) | 7.2 | 7.2 | 10.3 | 10.6 | 11.3 | 11.2 | 11.0 | 11.7 | 7.8 | 7.9 | 4.5 | 4.7 |
| Medical costs in outpatient per patient (thousand USD) | 1.9 | 2.1 | 3.3 | 3.3 | 3.9 | 3.7 | 2.8 | 3.1 | 8.8 | 9.6 | 3.1 | 3.5 |
| Anti‐cancer therapy | ||||||||||||
| No. of changes in anti‐cancer drugs | 4.6 ± 4.9 | 4.4 ± 4.7 | 4.9 ± 5.1 | 5.1 ± 5.3 | 6.0 ± 5.5 | 6.2 ± 5.7 | 3.4 ± 3.4 | 4.0 ± 4.3 | 5.9 ± 5.7 | 6.7 ± 6.2 | 4.6 ± 5.4 | 4.7 ± 5.7 |
| Anti‐cancer drug costs per patient (thousand USD) | 2.7 | 2.9 | 4.1 | 3.4 | 5.1 | 4.7 | 0.7 | 1.4 | 7.1 | 6.7 | 3.3 | 3.2 |
| Anti‐cancer drug costs in inpatient per patient (thousand USD) | 1.3 | 1.1 | 2.4 | 2.1 | 2.2 | 1.6 | 0.3 | 0.4 | 2.2 | 1.8 | 0.5 | 0.4 |
| Anti‐cancer drug costs in outpatient visit per patient (thousand USD) | 1.4 | 1.8 | 1.8 | 1.3 | 2.9 | 3.1 | 0.4 | 1.1 | 4.8 | 4.9 | 2.8 | 2.8 |
Plus‐minus values are means ± SD.